Literature DB >> 28889180

The degree of cartilage degradation assessed by serum biomarker levels changes after arthroscopic knee synovectomy in rheumatoid arthritis patients.

Marina Lipina1, Maxim Makarov2, Sergey Makarov2, Alexander Novikov2.   

Abstract

PURPOSE: In order to test the validity of the selected surgical technique as a way to manage persistent synovitis of the knee joint, as well as to slow down the cartilage and bone destruction, we studied the dynamics of biomarkers of inflammatory conditions, and bone and cartilage destruction after total arthroscopic synovectomy (TAS) of the knee joint.
METHODS: The sampling comprised 124 RA patients (158 knees) who had undergone the TAS procedure between 2003 and 2015. Before surgery the rheumatoid factor (IgM), C-reactive protein (CRP), erythrocyte sedimentation rate test was completed for all patients. Blood serum samples were collected (prior to surgery, and three, six and 12 months after surgery) and frozen at -70°С. The content of CRP, Matrix metalloproteinase-3 (MMP-3), Cartilage Oligomeric Matrix Protein, as well as cross-linked Ctelopeptides of types I and II were measured in blood serum by means of polarization fluoroimmunoassay with the use of a standard set of reagents.
RESULTS: The average duration of the disease in the studied group was 8.7 ± 6.6 years. Concentration of the inflammation markers showed that only MMP-3 displayed statistical significance.
CONCLUSIONS: The obtained results can be used as basis in assessing the efficiency and effectiveness of this method of treatment of persistent knee joint synovitis associated with the RA.

Entities:  

Keywords:  Biomarkers of bone and cartilage destruction; Rheumatoid arthritis; Total knee synovectomy

Mesh:

Substances:

Year:  2017        PMID: 28889180     DOI: 10.1007/s00264-017-3634-8

Source DB:  PubMed          Journal:  Int Orthop        ISSN: 0341-2695            Impact factor:   3.075


  24 in total

1.  Radiographic evaluation of rheumatoid arthritis and related conditions by standard reference films.

Authors:  A Larsen; K Dale; M Eek
Journal:  Acta Radiol Diagn (Stockh)       Date:  1977-07

2.  Inflammatory cytokines and biomarkers of cartilage metabolism 8 years after anterior cruciate ligament reconstruction: results from operated and contralateral knees.

Authors:  Martina Åhlén; Leyla Roshani; Mattias Lidén; André Struglics; Lars Rostgård-Christensen; Jüri Kartus
Journal:  Am J Sports Med       Date:  2015-03-18       Impact factor: 6.202

3.  Serum and synovial cartilage oligomeric matrix protein levels in early and established rheumatoid arthritis.

Authors:  A O El Defrawy; T A Gheita; H M Raslan; M M El Ansary; A H El Awar
Journal:  Z Rheumatol       Date:  2016-11       Impact factor: 1.372

4.  Can tocilizumab decrease cartilage oligomeric matrix protein levels and disease activity in patients with long-standing rheumatoid arthritis?

Authors:  Maurizio Benucci; Francesca Meacci; Mariangela Manfredi; Francesca Li Gobbi; Maria Infantino; Cristian Ricci; Piercarlo Sarzi-Puttini; Fabiola Atzeni
Journal:  Curr Rheumatol Rev       Date:  2014

5.  Low-level increases in serum C-reactive protein are present in early osteoarthritis of the knee and predict progressive disease.

Authors:  T D Spector; D J Hart; D Nandra; D V Doyle; N Mackillop; J R Gallimore; M B Pepys
Journal:  Arthritis Rheum       Date:  1997-04

6.  A new marker for osteoarthritis: cross-sectional and longitudinal approach.

Authors:  M Reijman; J M W Hazes; S M A Bierma-Zeinstra; B W Koes; S Christgau; C Christiansen; A G Uitterlinden; H A P Pols
Journal:  Arthritis Rheum       Date:  2004-08

7.  High serum cartilage oligomeric matrix protein determines the subset of patients with early-stage rheumatoid arthritis with high serum C-reactive protein, matrix metalloproteinase-3, and MRI-proven bone erosion.

Authors:  Keita Fujikawa; Atsushi Kawakami; Mami Tamai; Masataka Uetani; Shoichiro Takao; Kazuhiko Arima; Naoki Iwamoto; Toshiyuki Aramaki; Shinya Kawashiri; Kunihiro Ichinose; Makoto Kamachi; Hideki Nakamura; Tomoki Origuchi; Hiroaki Ida; Kiyoshi Aoyagi; Katsumi Eguchi
Journal:  J Rheumatol       Date:  2009-05-15       Impact factor: 4.666

8.  Cartilage oligomeric matrix protein and matrix metalloproteinase-3 expression in the serum and joint fluid of a reversible osteoarthritis rabbit model.

Authors:  X Q Chu; J J Wang; L D Dou; G Zhao
Journal:  Genet Mol Res       Date:  2015-11-13

9.  Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up.

Authors:  Mark Houseman; Catherine Potter; Nicola Marshall; Rachel Lakey; Tim Cawston; Ian Griffiths; Steven Young-Min; John D Isaacs
Journal:  Arthritis Res Ther       Date:  2012-02-07       Impact factor: 5.156

10.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.

Authors:  Susan Tseng; A Hari Reddi; Paul E Di Cesare
Journal:  Biomark Insights       Date:  2009-02-17
View more
  5 in total

1.  Citations, non-citations and visibility of International Orthopaedics in 2017.

Authors:  Andreas F Mavrogenis; Andrew Quaile; Marko Pećina; Marius M Scarlat
Journal:  Int Orthop       Date:  2018-11       Impact factor: 3.075

2.  Synovial fluid-derived exosomal lncRNA PCGEM1 as biomarker for the different stages of osteoarthritis.

Authors:  Ye Zhao; Juan Xu
Journal:  Int Orthop       Date:  2018-08-20       Impact factor: 3.075

3.  Arthroscopic synovectomy of the knee joint for rheumatoid arthritis.

Authors:  Marina Lipina; Maxim Makarov; Victor Mukhanov; Alexander Karpashevich; Sergey Maglevaniy; Vera Amirdjапоvа; Sergey Archipov
Journal:  Int Orthop       Date:  2018-10-03       Impact factor: 3.075

4.  Comparison of efficacy between anti-IL-6 receptor antibody and other biological disease-modifying antirheumatic drugs in the patients with rheumatoid arthritis who have knee joint involvement: the ANSWER cohort, retrospective study.

Authors:  Yuichi Maeda; Toru Hirano; Kosuke Ebina; Ryota Hara; Motomu Hashimoto; Wataru Yamamoto; Kosaku Murakami; Takuya Kotani; Kenichiro Hata; Yonsu Son; Hideki Amuro; Akira Onishi; Sadao Jinno; Masaki Katayama; Atsushi Kumanogoh
Journal:  Rheumatol Int       Date:  2021-04-26       Impact factor: 2.631

Review 5.  Exosomes in osteoarthritis: Updated insights on pathogenesis, diagnosis, and treatment.

Authors:  Wen-Jin Fan; Di Liu; Lin-Yuan Pan; Wei-Yang Wang; Yi-Lan Ding; Yue-Yao Zhang; Rui-Xi Ye; Yang Zhou; Sen-Bo An; Wen-Feng Xiao
Journal:  Front Cell Dev Biol       Date:  2022-07-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.